Accessibility Help | Sitemap | Contact Us | Customer Support Freephone 1 800 33 33 77
Ireland Change Country
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education & Training  |  For Patients  |  Customer Support
You are here: Home
Print

News & Media

These press releases are intended as reference information for investors and journalists. The information contained in each press release was current at the time of issuance, and KCI assumes no responsibility for updating the information to reflect subsequent developments.

Top Stories

KCI, Leader in Advanced Wound Care Solutions KCI, LifeCell and Systagenix Combine to Form One Company and Rebrand as Acelity

Acelity is Industry Leading Medical Technology Company with $2 Billion in Revenue

KCI, Leader in Advanced Wound Care Solutions Novel KCI Skin Graft Harvesting Tool Now Available in Europe

CelluTome™ System takes autologous grafting out of the OR

Headlines

Displaying 110 of 110 News Items
Show Less
3rd June 2014
New Study Reported Prevena™ Therapy Patients had a Significantly Lower Infection Rate Following Cardiac Surgery Compared to Control Group

Surgical incision management could generate savings of more than 60 million Euros in Germany alone

5th March 2014
Independent Study Shows V.A.C. VeraFlo™ Therapy More Beneficial Than Traditional V.A.C.® Therapy

Study Found Statistically Significant Reductions in OR Visits and Hospital Stay vs. Traditional V.A.C.® Therapy

14th January 2014
KCI Negative Pressure Wound Therapy with Instillation Supplement Published in International Wound Journal

Supplement Based on Presentations from the 2012 and 2013 International Surgical Wound Forums

8th January 2014
First International Consensus Guidelines Published for KCI Negative Pressure Wound Therapy with Instillation

Guidelines Published in Journal of Plastic and Reconstructive Surgery

11th November 2013
Growing Body of Evidence Supports V.A.C. VeraFlo™ Therapy Changing How Clinicians Approach Treating Wounds

Data Demonstrate Clinical and Economic Advantages of V.A.C. VeraFlo™ Therapy Compared to Traditional NPWT

28th October 2013
KCI Completes Acquisition of Systagenix

Peter Huntley Appointed Senior Vice President and Leader of Systagenix

26th August 2013
ABThera™ Open Abdomen Negative Pressure Therapy System Study Published in World Journal of Surgery

Significantly Improved Patient Outcomes Using ABThera™ Negative Pressure Therapy System in Open Abdomen Surgery

12th August 2013
KCI Introduces New V.A.C. VeraFlo™ Large Dressing

Taking Away the Large Burden of Wound Healing

30th July 2013
KCI to Acquire Systagenix

Strategic Transaction Strengthens KCI Leadership Position in Global Wound Care Market While Adding Diversification

Enhances Access to $3.4 Billion Advanced Wound Care Market, Leveraging KCI’s Well-Established Customer Relationships, Brand and Commercial Scale

Complementary Product Portfolio Will Advance Provision of Best-in-Class Solutions to Healthcare Professionals and Patients
 

9th July 2013
KCI Launches Novel Tool to Simplify Epidermal Harvesting

CelluTome™ Epidermal Harvesting System makes harvesting and subsequent grafting of epidermis accessible to more clinicians and patients

20th June 2013
KCI Initiates Negative Pressure Wound Therapy with Instillation Randomized, Controlled Prospective Study

Study to Compare Traditional Negative Pressure Wound Therapy to V.A.C. VeraFlo™ Instillation Therapy, using the V.A.C.Ulta™ Negative Pressure Wound Therapy System

22nd May 2013
KCI Launches Prevena™ Peel & Place™ Dressing with V.A.C.® Therapy Connector

Benefits of surgical incision management now available to more patients

16th May 2013
New Study Reports Key Findings for the ABThera™ Open Abdomen Negative Pressure Therapy System

Observational Study Showed Significantly Improved Patient Outcomes When the ABThera™ Negative Pressure Therapy System was Used in Open Abdomen Surgery

7th May 2013
Independent Study Showed Decrease in Operating Room Visits for Patients with Infected Wounds using Adjunctive V.A.C. VeraFlo™ Therapy

Trend to Reduction in Hospital Stay vs. Traditional Negative Pressure Wound Therapy

5th March 2013
New Retrospective Study Reports Greater Effectiveness of KCI ABThera™ System Compared to Traditional Technique

Authors Conclude Significantly Greater Success with Ultimate Closure after Open Abdomen Management Compared to Barker Vacuum Pack Technique

18th December 2012
KCI Acquires New Skin Grafting Technology

KCI Announces the Completion of its Acquisition of MoMelan Technologies, Inc.

 

5th December 2012
KCI Announces New Board Member

Timothy E. Guertin Selected to Join Board of Directors

 

3rd December 2012
KCI Announces New Prevena™ Incision Management System Study

Study Shows Positive Results for Prevena™ Incision Management System in Management of Closed Surgical Incisions for Obese Patients.

9th November 2012
KCI Introduces Canadian Clinicians to the Next Evolution in V.A.C.® Therapy Technology

V.A.C.Ulta Negative Pressure Wound Therapy System Combines Proven V.A.C.® Therapy with New V.A.C. VeraFlo Therapy to Cleanse, Treat and Heal Wounds

8th November 2012
KCI Sells Therapeutic Support Systems Business

Sale finalized November 8th to Getinge AB

 

12th September 2012
KCI Expands Operations in Brazil

Global Leader in Wound Management will Provide Specialist Training to Local Healthcare Professionals to Improve Patient Outcomes

15th August 2012
KCI Agrees to Divest its Therapeutic Support Systems™ Business to Getinge AB

Kinetic Concepts, Inc. announced that it has signed a definitive agreement to sell its Therapeutic Support Systems™ business to Getinge AB.

2nd July 2012
Mike Mathews Named Senior Vice President, International at KCI

Mathews to Lead Commercial Business Activities in International Markets

15th June 2012
Evidence Grows in Support of Prevena™ Incision Management System to Manage Closed Surgical Incisions

Results from clinical study demonstrated a significant patient benefit in using Prevena™ Therapy on this patient population.

14th June 2012
KCI Announces FDA 510(k) Clearance of V.A.C.® Therapy for Management of Closed Surgical Incisions

Kinetic Concepts, Inc. announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) to market its proprietary Vacuum Assisted Closure®, or V.A.C.® Therapy System, for the management of closed surgical incisions.

23rd May 2012
Peter Arnold Named Senior Vice President of Innovation and Strategic Marketing at KCI

Kinetic Concepts, Inc. announced today that Peter Arnold has been named Senior Vice President of Innovation and Strategic Marketing.

15th May 2012
Jim Cunniff Named Senior Vice President, Leading Commercial Activities in the Americas for KCI

Kinetic Concepts, Inc. announced today that James (Jim) Cunniff has been named Senior Vice President of the Americas.

17th April 2012
Abstract Published in Canadian Journal of Surgery Reports Key Preliminary Findings of Major Prospective Study of the KCI ABThera™ Open Abdomen Negative Pressure Therapy System

Kinetic Concepts, Inc. announced today that an abstract referring specifically to the KCI ABThera Open Abdomen Negative Pressure Therapy System (ABThera OA NPT), states that this "prospective cohort study observed a reduction in mortality (RR 0.48, 95% CI 0.25-0.92) and an increased fascial closure rate (RR 1.5, 95% CI 1.1 – 2.0) in patients who received the ABThera versus [Barker's technique] vacuum pack."

27th January 2012
KCI Announces New Management Structure

The Board of Directors of the parent company of Kinetic Concepts, Inc. and LifeCell Corporation today announced that Ronald A. Matricaria has joined the Board of Directors and will serve as its Chairman.

15th December 2011
KCI Supports CHRISTUS Santa Rosa Children’s Hospital Foundation with $20,000 Gift through Cards for Kids Program

KCI today announced a $20,000 gift to CHRISTUS Santa Rosa Children's Hospital Foundation to support many of the hospital's multidisciplinary programs for young patients in San Antonio and South Central Texas.

7th September 2011
KCI’s V.A.C.Via™ Therapy System Named a Leading Innovation by Podiatry Today

KCI today announced that its V.A.C.Via Therapy System was named one of the "Top Ten Innovations in Podiatric Technology" by trade publication Podiatry Today.

26th August 2011
KCI Responds to Hurricane Irene

Information for Customers and Patients affected by Hurricane Irene

30th June 2011
KCI's V.A.C.Via™ Therapy System to be Listed on U.K. Drug Tariff

V.A.C.Via System Has the Potential to Save National Health Service Money; Provides Benefits to Patients and Clinicians

29th June 2011
KCI Awarded the Maximum Regional Contracts for NPWT in Germany

Facilitates Improved Patient Care and Access; Positions KCI as a Leader in the Region

17th June 2011
Academy of Wound Technology and KCI Announce Launch of Transcontinental Wound Registry

Registry to Provide Clearer Insights Into Economic and Clinical Outcomes; Set to Debut at 2012 WUWHS Congress

7th June 2011
Over $1 Million in KCI Wound Care Equipment Arrives in Joplin, Mo. To Aid Tornado Victims

Donation Helps Area Health Care Providers Treat Those Injured in the Disaster

17th May 2011
KCI's TSS Business Unit Announces First Non-Foam-Based Pressure Redistribution Surface Available in U.S. for Patients up to 1000 Pounds

AtmosAir Fit MRS Sets a New Benchmark in the Challenge to Ensure Skin Integrity and Pressure Ulcer Prevention for Morbidly Obese Patients

16th May 2011
Kinetic Concepts, Inc. Announces Plans to Declassify Its Board of Directors

Kinetic Concepts, Inc. announced today that the Board of Directors of KCI has determined that it will amend KCI's By-Laws prior to the 2012 annual meeting of shareholders to declassify the Board of Directors.

12th April 2011
KCI Names John Bibb as General Counsel

Kinetic Concepts, Inc. announced today that John Bibb has been promoted to general counsel for the company.

4th April 2011
KCI Announces Plans for New Global Headquarters To Accommodate Growth, Expansion

Kinetic Concepts, Inc., a global leader in healing and regeneration, today announced plans for and broke ground on a new global headquarters in San Antonio.

31st January 2011
KCI Licenses Wright Medical’s GRAFTJACKET® Brand for Wound Care

Deal Enables Full Commercialization of Regenerative Tissue Matrix Technology for Wound Care Patients, Including Those with Diabetic Foot Ulcers

10th January 2011
KCI to Expand Product Portfolio Through Acquisition of TechniMotion™ Patient Handling Technologies

Kinetic Concepts, Inc. announced the acquisition of substantially all of the assets and intellectual property of TechniMotion Medical, an Austin, Texas-based company that designs and develops innovative and ergonomic patient handling systems for acute and post-acute patient care.

18th November 2010
Validity of KCI Patents Upheld in United Kingdom

Smith & Nephew's NPWT Products Found To Infringe

27th October 2010
New therapeutic surface from KCI enhances skin integrity for the prevention and management of pressure ulcers

Skin IQ Microclimate Manager Helps Reduce Skin Moisture, Temperature, Friction and Shear

24th August 2010
New KCI Product Designed to Manage Incisions Following Surgery, Such as General, OB/GYN, Orthopedic, Cardiac Procedures

Prevena Incision Management System now available to all U.S. hospitals

16th August 2010
KCI Obtains Favorable Ruling in German Patent Case

Court Finds Smith & Nephew's Renasys EZ Product Infringes KCI Patent; Issues Injunction

29th July 2010
KCI Obtains Injunction against Smith & Nephew in United Kingdom

UK High Court of Justice Enters Injunction Against Smith & Nephew’s NPWT Products; Injunction Stayed Pending Expedited Appeal

13th July 2010
KCI Boosts Research and Development Capabilities with Launch of Advanced Research and Technology Center

Innovation Center to Accelerate Company Mission of Making Healing Possible; New Organization Will Fuel Product Development and Commercialization

23rd June 2010
KCI Wins UK Patent Case Against Smith & Nephew

UK High Court of Justice Finds Smith & Nephew's Products Infringe Two NPWT Patents Exclusively Owned By KCI

22nd June 2010
KCI Prevena™ Incision Management System Licensed by Health Canada

Designed to Help Manage Patients' Incisions Successfully Following Surgery

16th June 2010
KCI Receives FDA Clearance for Prevena™ Incision Management System

Postsurgical Incision Management Represents $1 Billion Global Market Opportunity: U.S. Approval Follows Prevena System Launch in Europe and Canada

3rd June 2010
KCI First Manufacturer to Commit to Submitting Product Labeling for FDA Medical Device Home Use Initiative

Move Signals KCI's Support of FDA's Goal of Ensuring Strong Standards for Patient Home Use

28th May 2010
KCI Announces FDA Clearance of V.A.C.® Therapy for Venous Insufficiency Ulcers

Extends KCI's Reach Across All Three Major Chronic Wound Types

25th May 2010
International Consensus Document Offers Greater Clarity on Treatment and Prevention of Pressure Ulcers

New insights from global experts on pressure ulcers to be released at the 20th Conference of the European Wound Management Association (EWMA) in Geneva

25th May 2010
KCI to Feature Full Range of Negative Pressure Technology Platform at EWMA

KCI will launch its full range of new NPTP products and support the release of a consensus document on pressure ulcer prevention titled International Review - Pressure, Shear, Friction and Microclimate in Context

11th May 2010
KCI Appoints Ron Silverman, M.D., FACS, Chief Medical Officer

Latest Innovation Provides Groundbreaking Design in Negative Pressure Wound Therapy

26th April 2010
KCI to Launch the V.A.C.VIA™, an Advanced Mobile Healing Technology

Latest Innovation Provides Groundbreaking Design in Negative Pressure Wound Therapy

21st April 2010
KCI Appoints Kien Nguyen Vice President of Global Marketing for Active Healing Solutions™

Will Oversee Global Market Development for Negative Pressure Technology Platform

15th April 2010
KCI to Feature Unparalleled Range of NPTP Products and Services at SAWC

Negative Pressure Symposium and Conference Exhibit to Focus on KCI's Ongoing Commitment to Improve and Simplify Negative Pressure Treatments

1st April 2010
KCI Announces First Patient Placement of V.A.C. Therapy in Japan

Launch of Innovative Therapy Represents First Step in Broader Product Introduction and Market Development Strategy

18th March 2010
KCI Launches the Prevena™ Incision Management System in Europe and Canada

Prevena System First and Only Powered Negative Pressure Product Designed to Manage Incisions at Risk of Complication

10th March 2010
KCI Wins Patent Case Against Smith & Nephew

United States District Court Jury Finds that Smith & Nephew’s Product Infringes Wake Forest Patents Licensed to KCI

8th March 2010
KCI Announces Reimbursement Approval in Japan

Reimbursement Clears Way to Commercialize KCI’s Revolutionary V.A.C.® Therapy System in Japan

4th March 2010
KCI Launches Rotoprone™ Therapy System Web Site Showcasing Strong Clinical Evidence

New Site, RotoProne.com, Dedicated to Clinician Education on Managing Patients with Severe Respiratory Distress

1st March 2010
KCI First Commercial Entity to Receive Nursing Skills Competency Program™ Accreditation from American Nurses Credentialing Center

KCI Shows Commitment to Product Education by Accreditation through Nursing Skills Competency Program

20th January 2010
KCI Pledges additional Haiti Relief

Disaster has a way of bringing us together. Today KCI has come together as a company to address the significant needs of the people in Haiti. As you know, KCI has been able to donate our products, and now we’d like to help stretch the impact of donations employees may choose to make to the Haiti relief efforts.

19th January 2010
KCI Sends Critically Needed Medical Products to Haiti to Help Treat Seriously Wounded

KCI Donates its Signature V.A.C.® Therapy and Other Wound Care Products; In-Kind Donation Valued at More Than $2 Million

2nd November 2009
KCI Announces Final Approval to Enter Japan Market

Formal regulatory approval enables commercialization of innovative V.A.C.® Therapy System in Japan.

21st October 2009
Kinetic Concepts Reports Financial Results for Third Quarter and First Nine Months of 2009

Kinetic Concepts, Inc. (NYSE: KCI) today reported third quarter 2009 total revenue of $504.4 million, compared to $503.3 million reported for the third quarter of 2008.

12th October 2009
KCI honors Dr. Louis Argenta with research-based fellowship and scholarship

Grant celebrates the conception of Negative Pressure Wound Therapy

12th October 2009
KCI Hosts Investigator Meeting for New Multicenter Observational ABTAC Study during American College of Surgeons' Clinical Congr

Hosts Open Abdomen Management Symposium Featuring Top Surgical, Critical Care Experts

9th October 2009
Australian Appeals Court Lifts Temporary Injunction Against Smith & Nephew Foam Dressing Kit

Full Court of The Federal Court of Australia, Victoria District Registry has lifted a temporary injunction in KCI’s patent litigation with Smith & Nephew (LSE: SN, NYSE: SNN).

30th September 2009
KCI Highlights ABThera™ Open Abdomen Negative Pressure Therapy System at American Association for the Surgery of Trauma Conference Symposium

Company Also Introduces New U.S. Open Abdomen Management System Clinical Guidelines

18th September 2009
KCI Reunited with Formerly Conjoined Egyptian Twins after Landmark Surgery

Ahmed and Mohamed Ibrahim, the eight-year-old craniopagus twins successfully separated during a well-documented and risky 34-hour operation in 2003, will visit Kinetic Concepts Inc. (KCI) Friday for a celebratory reunion.

18th September 2009
KCI Sponsors Georgetown Diabetic Limb Salvage Conference Symposium Featuring Top Limb Preservation Experts

Kinetic Concepts, Inc. (KCI) will sponsor a CME-accredited panel discussion, “The Role of NPWT in the Team Approach to Limb Salvage: Case Studies,” at the 3rd Annual Georgetown Diabetic Limb Salvage conference September 24-26.

8th September 2009
KCI Announces Expected Regulatory Approval to Enter Japan Market

KCI announced today that it has been informed by the Pharmaceutical and Medical Devices Agency in Japan that in October the Ministry of Health, Labor and Welfare will grant regulatory approval for KCI to begin market development activities in Japan for its innovative V.A.C.® Therapy product.

28th August 2009
Kinetic Concepts, Inc. to Participate in the Thomas Weisel Partners Healthcare Conference 2009

Kinetic Concepts, Inc. (NYSE:KCI) today announced that Catherine Burzik, President and Chief Executive Officer, will present at the Thomas Weisel Partners Healthcare Conference 2009 at the Four Seasons Hotel in Boston, Massachusetts.

4th August 2009
KCI Launches Innovative ABThera(TM) Open Abdomen Negative Pressure Therapy System to Help Manage Patients with Severe Conditions

Kinetic Concepts, Inc. (NYSE: KCI), today announced the official launch of ABThera™ open abdomen negative pressure therapy system, the latest addition to its Negative Pressure Technology Platform (NPTP).

24th July 2009
United States Patent and Trademark Office Confirms Validity of KCI Negative Pressure Wound Therapy Patents

Kinetic Concepts, Inc. (NYSE: KCI) today announced that the U.S. Patent and Trademark Office (USPTO) issued Office actions confirming the validity of three separate patents licensed to KCI by Wake Forest University Health Sciences in re-examination proceedings.

15th July 2009
KCI Appoints Michael Genau to New Global Leadership Position That Directs Expansion of Current Wound Therapy Division

Kinetic Concepts, Inc. (NYSE: KCI) announced today that Michael Genau has joined the Company in the newly formed position of Global President, Wound Therapy.

14th July 2009
KCI Announces Intention to Appeal UK Court Ruling Revoking NPWT Patent

Kinetic Concepts, Inc. (NYSE: KCI) announced today that the Court of Appeal of England and Wales has revoked a patent licensed to KCI from Wake Forest University.

13th July 2009
Department of Health (DH) highlights V.A.C.(R) Therapy As Having High Potential in Improving Community-Based Wound Care

Improving wound care in the community may be the fastest route to reach some of Lord Darzi’s proposed quality improvements for the NHS. And using KCI’s V.A.C.®

9th July 2009
Kinetic Concepts, Inc. Announces Date of its Second Quarter 2009 Earnings Release and Conference Call

Kinetic Concepts, Inc. (NYSE:KCI), today announced that it will report its second quarter 2009 financial results on Tuesday, July 21, 2009, at 6:00 a.m. EDT.

15th June 2009
Australia Court Issues Temporary Injunction Prohibiting Smith & Nephew from Selling Negative Pressure Wound Therapy Foam Dressing Kit

Kinetic Concepts, Inc. (NYSE: KCI) announced today that The Federal Court of Australia, Victoria District Registry, issued a temporary injunction prohibiting Smith & Nephew (LSE: SN; NYSE: SNN) from selling foam dressing kits for negative pressure wound therapy in Australia until the court can rule on the patent infringement action brought against Smith & Nephew by KCI.

20th May 2009
KCI and YHEC Launch Flexible New Evidence-based Tool to Help Hospitals Optimize Pressure Ulcer Treatment Strategies

Kinetic Concepts, Inc. in conjunction with The York Health Economics Consortium (YHEC) will launch a new Budget Impact Model (BIM) for wound care surfaces at the European Wound Management Association (EWMA) Conference in Helsinki .

17th March 2009
KCI Introduces new V.A.C. GranuFoam Bridge Dressing

KCI announced today the U.S. market launch of its new V.A.C.® GranuFoam™ Bridge Dressing, further expanding the portfolio of dressings used in the treatment of chronic wounds. This new dressing is expected to simplify application in chronic wounds, especially Diabetic Foot Ulcers (DFUs) where it is compatible with off-loading devices.

14th January 2009
KCI 2008 Earnings Release

13th January 2009
KCI Obtains Temporary Injunction in the United Kingdom Against Smith & Nephew Foam Dressing Kit

Kinetic Concepts, Inc. (NYSE:KCI) announced today that a temporary injunction against Smith & Nephew has been granted by the Specialist Patents Court in the High Court of Justice of England and Wales.

6th January 2009
Kinetic Concepts, Inc. to Present at the 27th Annual JPMorgan Healthcare Conference

Kinetic Concepts, Inc. (NYSE:KCI) today announced that Catherine Burzik, President and Chief Executive Officer, will present at the 27th Annual JPMorgan Healthcare Conference in San Francisco.

Displaying 110 of 110 News Items
Show Less

  • Share on Facebook.com
  • Share on Twitter
  • Visit our YouTube page

Important Message for Patients

Legal Notice | Privacy Policy | Contact Us


Copyright © 1998 – 2013 KCI Licensing, Inc All Rights Reserved.   DSL# 09-03-193.IE

The information included in this Web site has been prepared for and is intended for viewing exclusively within the Republic of Ireland. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications and restriction in different countries.